← Back to patent-cliff list
CAS 95716-71-5
(10R,13S,17R)-10,13-dimethyl-1,3',4',8,10,12,13,14,15,16-decahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione
Codes: EPLE-008
Application context (from source-drug indications)
HypertensionEplerenoneHeart failureEplerenone醛固酮增多症EplerenoneMyocardial infarctionEplerenoneChronic renal impairmentEplerenoneEssential hypertensionEplerenone
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Eplerenone | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
methyl (7R,10S,13S,17R)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylate→(10R,13S,17R)-10,13-dimethyl-1,3',4',8,10,12,13,14,15,16-decahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione→(7R,10S,13S,17R)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carbonitrile→(7R,10S,13S,17R)-3-hydroxy-10,13-dimethyl-5'-oxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carbaldehyde→(7R,10S,13S,17R)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylic acid
methyl (7R,10S,13S,17R)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylate→(10R,13S,17R)-10,13-dimethyl-1,3',4',8,10,12,13,14,15,16-decahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione→(7R,10S,13S,17R)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylic acid→2-methylfuran→(7R,8R,10S,13S,14S,17R)-10,13-dimethyl-7-(5-methylfuran-2-yl)-1,3',4',6,7,8,10,12,13,14,15,16-dodecahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione→2-methyl-1-(vinyloxy)propane→(7R,8R,10S,13S,14S,17R)-10,13-dimethyl-7-((E)-4-oxopent-2-enoyl)-1,3',4',6,7,8,10,12,13,14,15,16-dodecahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione→(7R,8R,10S,13S,14S,17R)-7-(2-hydroxy-2-methoxyacetyl)-10,13-dimethyl-1,3',4',6,7,8,10,12,13,14,15,16-dodecahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione→(1'R,2R,3a'R,7a'R,9a'S,12a'S,12b'R)-7a',9a'-dimethyl-1',3,4,6',7',7a',9',9a',11',12',12a',12b'-dodecahydro-2'H,5H-spiro[furan-2,10'-[1,3a]methanobenzo[b]indeno[5,4-d]oxepine]-2',5,5'(4'H)-trione
(10R,11R,13S,17R)-11-hydroxy-10,13-dimethyl-1,3',4',8,9,10,11,12,13,14,15,16-dodecahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione→(10R,13S,17R)-10,13-dimethyl-1,3',4',8,10,12,13,14,15,16-decahydro-5'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H)-dione→(1'R,2R,3a'R,7a'R,9a'S,12a'S,12b'R)-7a',9a'-dimethyl-1',3,4,6',7',7a',9',9a',11',12',12a',12b'-dodecahydro-2'H,5H-spiro[furan-2,10'-[1,3a]methanobenzo[b]indeno[5,4-d]oxepine]-2',5,5'(4'H)-trione→(10R,11R,13S,17R)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',8,9,10,11,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-11-yl methanesulfonate→(1'R,2R,3a'R,7a'R,9a'S)-7a',9a'-dimethyl-1',3,4,6',7',7a',9',9a',11',12',12a',12b'-dodecahydro-2'H,5H-spiro[furan-2,10'-[1,3a]methanobenzo[b]indeno[5,4-d]oxepine]-5,5'(4'H)-dione→3-methyl-3-(trifluoromethyl)dioxirane→(1'R,2R,2'S,3a'R,7a'R,9a'S)-2'-hydroxy-7a',9a'-dimethyl-1',3,4,6',7',7a',9',9a',11',12',12a',12b'-dodecahydro-2'H,5H-spiro[furan-2,10'-[1,3a]methanobenzo[b]indeno[5,4-d]oxepine]-5,5'(4'H)-dione
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.